Higgins joins WORT to talk about future of medication abortion in Wisconsin

Jenny Higgins, PhD, MPH, director of the UW Ob-Gyn Division of Reproductive and Population Health and the UW Collaborative for Reproductive Equity, spoke with WORT Community Radio in Madison about recent federal court rulings around FDA approval of the drug mifepristone and what it could mean for abortion and miscarriage patients.

In “What Now For Medication Abortions?”, Higgins discussed medication abortion restrictions in Wisconsin prior to the overturning of Roe v. Wade, national data about changes in abortion access across the United States since June 2022, and what decisions about mifepristone might mean for self-managed abortions:

“There was one ruling in recent weeks that had an important implication that restricted the use of mail for mifepristone distribution. So essentially, if that particular case were to come through, it would be against the law everywhere to ship and receive mifepristone by mail. And that in Wisconsin would potentially increase the criminalization of people who use self-managed medication abortions.”

Listen to the whole interview here.